Work

Figure S2 from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer

Year: 2023

Type: other

Abstract: Supplementary Figure S2. Kaplan Meier survival analysis evaluating association of PD-L1+ (SP142 assay with {greater than or equal to}1% IC+, in red) to PD-L1- tumors (SP142 assay <1% IC+ in black) with recurrence-free survival (RFS) (A) or overall survival (B) in the entire TNBC cohort.

DOI: 10.1158/1078-0432.24263012.v1

Authors: Jodi M. Carter, Mei-Yin C. Polley, Roberto A. Leon-Ferre, Jason Sinnwell, Kevin J. Thompson, Xue Wang, Yaohua Ma, David Zahrieh, Jennifer M. Kachergus, Malvika Solanki, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, E. Aubrey Thompson, Matthew P. Goetz

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4387397004

Cites:

Cited by:

Related to: 10